To evaluate factors related to the occurrence of Sheehan syndrome.
Introduction
Sheehan syndrome is the name given to postpartum hypopituitarism and is caused by an infarction in the adenohypophysis, usually precipitated by massive uterine hemorrhage. Sheehan While the incidence is low, being 1 out of 10,000 cases of delivery 2 , it is a serious disease, and its pathological factors largely remain unclear. It is a hazardous disease that may not only impair the quality of life of women but also may threaten life if left untreated. Mild hypopituitarism can remain undetected for years but complete loss of adenohypophysis function requires immediate treatment. Therefore, careful follow-up intervention for early diagnosis and proper management of patients with Sheehan syndrome is mandatory. However, information on the suitable clinical factors related to the occurrence of Sheehan syndrome is scanty.
In our current study, we followed-up a group of women had suffered from massive hemorrhage during delivery to identify the possible occurrence of Sheehan syndrome. Secondly, we plan to analyze a number of obstetrical factors and hormonal parameters in these women during the course of follow-up.
Subjects and Methods
All subjects in this study were women of reproductive age who attended our University hospital for screening and follow-up after achieving pregnancy. A total of nine women who suffered from massive hemorrhage during delivery was followed-up for a period of 13-80 months to identify any subsequent occurrence of Sheehan syndrome.
Massive hemorrhage was defined as a loss of ≥3,000g of blood including amniotic fluid.
Mean age ranges from 29-41years and gestational week at delivery ranges from 31wks-41wks in these women. All women had at least one or more than one children.
During this follow-up period, any woman suspected to have Sheehan syndrome on the basis of clinical findings and hormonal profiles were referred to the Department of Internal Medicine of our University for final diagnosis by MRI.
Our current study is in accordance with the guidelines of the Declaration of Helsinki and was performed with the approval by the Institutional Review Board of Nagasaki University. An informed consent was obtained from all participated women.
The obstetrical DIC score, total volume of hemorrhage, shock index (S.I.), level of consciousness, electrolyte levels, and pituitary MRI findings were evaluated in these women. The S.I. was shown as the maximum value during shock, and the level of consciousness was graded according to the criteria of Glasgow Coma Scale (GCS). 4 The GCS criteria is based on a scoring system depending on eye response (score 1-4), verbal response (score 1-5) and motor response (score 1-6). A tendency towards higher GCS score indicates good consciousness level and a tendency towards decreased GCS score denotes bad consciousness level. The scoring system of consciousness level as measured by Japan Coma Scale (JCS) is somehow similar to that of GCS score.
Serum levels of hormones being secreted by the anterior lobe of the pituitary gland such as growth hormone (GH), luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL), thyroid stimulating hormone (TSH), and adrenocorticotropic hormone (ATCH) as well as estradiol (E2), insulin-like growth factor 1 (IGF-1), free thyroxine (FT4), and cortisol were measured by commercial based Immulyze assay.
All results are expressed as mean ± SD. The clinical characteristics of the subjects were compared with one-way analysis of variance. Any difference of clinical factor or hormonal profile between two groups was analyzed by the non-parametric Mann-Whitney U-test or Student's t-test. Due to small number of cases in each group, we confirmed the validity of our results by Fisher's exact test. A value of p<0.05 was considered statistically significant.
Results
During the follow-up period after postpartum massive hemorrhage, three cases were diagnosed as Sheehan syndrome (Sheehan group) and the remaining six cases did not develop Sheehan syndrome despite massive hemorrhage during delivery (non-Sheehan group). Obstetrical backgrounds of these two groups of cases are shown in Table 1 . Symptoms suggestive of deficiency of pituitary anterior lobe hormones such as breast atrophy, poor milk secretion, hair loss, and malaise were observed from early in the puerperal period in the Sheehan group but not in the non-Sheehan group. The clinical backgrounds of three cases in the Sheehan group are described here briefly. 
CASE 3
In June 2008, this patient (38 yrs old) underwent induction of labor using oxytocin for weak pain and subsequently an emergency Caesarean section was performed due to placental abruption. Uterine bleeding did not stop due to atonic bleeding even after abdominal closure, and the patient was transferred to our department for emergency treatment. After arrival, bleeding was stopped using a uterine contractor. No milk secretion was observed after surgery, amenorrhea persisted even 8 months after surgery, and the blood estradiol level was low. Therefore, HRT was initiated one year and five months after surgery. Easy fatigability, headache, dizziness, and loss of libido were also noted after surgery. Two years after surgery, pituitary anterior lobe hormone stimulation tests were performed, and a diagnosis of Sheehan syndrome was made by abnormal hormonal profiles (LH and FSH: low response, PRL: low response, TSH, ACTH, cortisol: normal response, and growth hormone deficiency). Table 2 shows the obstetrical DIC score, total volume of hemorrhage, shock index (S.I.), status of consciousness level, and findings on pituitary MRI in 9 cases.
Between Sheehan and non-Sheehan groups, the total volume of hemorrhage was 9143.3g (Table 3) . Serum E2 level was undetectable (below cut off value, <10pg/ml) in all cases with Sheehan syndrome in contrast to cases in the non-Sheehan group, Therefore, we could not analyze statistical difference of E2 levels between these two groups ( Table 3) . A statistically significant increase in basal hormone levels of ACTH (p=0.011) and decrease in levels of IGF-1 (p=0.048) was observed in the Sheehan group than in non-Sheehan group. Two cases of Sheehan syndrome with low cortisol level are now under treatment with cortical by doctor of Internal medicine in order to optimize the level of ACTH to the level of non-Sheehan group. Another case with Sheehan syndrome was not indicated for cortisol treatment because basal cortisol level in this case was similar to that in non-Sheehan group. We also observed an increased tendency in TSH levels in sera (p=0.061) of patients in the Sheehan group.
Although data not shown, we also measured a number of electrolyte levels in the sera of patients in the Sheehan and Sheehan group. Serum levels of sodium were markedly reduced to 124 mEq/L in two cases in the Sheehan group and levels of sodium were within normal range in all cases in the non-Sheehan group (data not shown). After correction for albumin, serum calcium level was still low in both groups without showing any difference between these two groups (data not shown).
Discussion
Sheehan syndrome is a permanent secretion disorder of all pituitary anterior lobe hormones caused by extensive pituitary necrosis secondary to obstetrical shock accompanied by DIC following massive hemorrhage during delivery. No pituitary dysfunction develops if about 50% of the normal pituitary gland remains intact, 3 but partial or panhypopituitarism is reported to occur if 70-90% of the pituitary gland is necrosed. 5 Depending on the site and size of the necrosed area of the pituitary gland, the disease varies from panhypopituitarism (Sheehan syndrome), in which the secretion of all gonadal, thyroid, and adrenocortical hormones is reduced, to partial hypopituitarism, in which the secretion of 2 or more hormones is reduced, and to single-hormone hypopituitarism, in which the secretion of only one hormone is reduced.
In our current study of nine cases with massive post-partum hemorrhage, we could detect three cases with Sheehan syndrome after combined and careful follow-up of these patients by Obstetrics doctors and doctors from Internal Medicine. All these three cases showed necrotic pituitary gland on MRI image and significant decrease in serum levels of at least two hormones (estradiol/IGF-1) when compared with cases in the non-Sheehan group. In fact, we found a decreased tendency of all pituitary anterior lobe, gonadal and thyroid hormones (except ACTH) in cases with Sheehan syndrome. Among all measured hormone levels in sera, we found significantly increase/decrease in the basal levels of ACTH/IGF-1, respectively and an increased tendency in the levels of TSH in cases in the Sheehan group than in non-Sheehan group. All other decreased or undetectable hormone levels in Sheehan group failed to achieve a significant difference comparing to non-Sheehan group. This could be due to small number of cases in each group.
There is a mutual feed-back loop between ACTH and cortisol. The minimal decrease of cortisol level in Sheehan group (Table 3) Besides reduction in hormone levels, we also found a significant increase in DIC score and significantly decreased levels of consciousness in patients with Sheehan syndrome. We could not find any significant difference in the total volume of hemorrhage or shock index between these two groups. This might be due to less number of cases in our current study.
It has been reported that deficiency of milk secretion is a frequent initial symptom of Sheehan syndrome, that symptoms such as breast atrophy, sense of fatigue, loss of pubic and axillary hair, and continuation of amenorrhea, and that hypothyroidism and hypoadrenalism are observed for several months to a few years. Sert et al. reported insufficiency of milk secretion in 26 of 28 patients diagnosed with Sheehan syndrome, 6 and Kelestimur mentioned insufficiency of milk secretion as one of the diagnostic criteria for Sheehan syndrome. 7 Of the 3 patients with Sheehan syndrome encountered at our department, insufficiency of milk secretion was observed in 2, and it is considered to be an important early puerperal symptom that may suggest Sheehan syndrome. Together with insufficient gonadotropin secretion, subsequent onset of breast atrophy and loss of pubic and axillary hair may be considered as an early indication of Sheehan syndrome as we experienced in our three cases. Although GCS scoring system is internationally recognized to measure levels of consciousness, as an additional marker, we found in our current study that JCS was also equally useful for the evaluation of consciousness level. 7 In fact, similar to decreased GCS scores, we also found a score of JCS II-30 and/or JCS III-300 in all cases with Sheehan syndrome. The decreased levels of consciousness in cases with Sheehan syndrome can be explained by hyponatremia as we observed in two of our three cases. 
Hyponatremia in patients with
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